PROCARE HEALTH
Procare Health is a Spanish pharmaceutical laboratory with an international vocation specialized in women’s health. In our first decade of life, we have launched innovative products, formulated with bio-optimized ingredients of natural origin, that have revolutionized the quality of life of women around the world
Procare Health is a Spanish pharmaceutical laboratory with an international vocation specialized in women’s health. In our first decade of life, we have launched innovative products on the market, formulated with bio-optimized ingredients of natural origin, which have revolutionized the quality of life of women around the world
PROCARE HEALTH
We are scientists by definition and we are constantly seeking to improve our products, but also to study their effects. For this reason, we allocate up to 25% of our budget to R&D and carry out ambitious international clinical research studies
PROCARE HEALTH
We are scientists by definition and we constantly seek to improve our products, but also to study their effects. For this reason, we allocate up to 25% of our budget to R&D and carry out ambitious international clinical research studies
INTERNACIONALIZACIÓN
With less than 10 years in business, we have established ourselves in different countries of Europe and we have also managed to reach other continents. We are present in more than 60 different countries, including the recent entry into the Chinese market.
INTERNACIONALIZATION
With less than 10 years of life, we have established ourselves in different European countries and we have also managed to reach other continents. We are present in more than 60 different countries, including the recent entry into the Chinese market
From the press area, you can closely follow all the news about our company
Women who have ovarian cancer are to receive a new vaccine that experts hope could give them years of extra life. Survival rates for the disease, which claims more than 4,000 lives a year in Britain…
The Fortune report projected that The global Human Papillomavirus (HPV) Vaccine market size was valued at USD 3.80 billion in 2019 and is projected to
Under the terms of the agreement, which was executed on February 9th, 2021, the companies will jointly conduct a Phase I Clinical Study of BVX-0918A in Spain, BioVaxys’ autologous haptenized protein vaccine for late-stage ovarian cancer…
SOCIAL HEADQUARTER
Avda. Miguel Hernández 21, Bajo
46450 Benifaio (Valencia – Spain)
BUSINESS HEADQUARTER
Paseo del Ferrocarril, 339 08860 Castelldefels, Barcelona +34 93 645 54 41 [email protected]
SOCIAL HEADQUARTER
Avda. Miguel Hernández 21, Bajo
46450 Benifaio (Valencia – Spain)
BUSINESS HEADQUARTER
Paseo del Ferrocarril, 339 08860 Castelldefels, Barcelona +34 93 645 54 41 [email protected]
© 2021 Procare Health
